Randomized controlled trial of Shuanghuang formula in the treatment of patients with Persistent inflammatory immunosuppressed catabolic syndrome (PICS)
- Conditions
- Sepsis
- Registration Number
- ITMCTR2024000097
- Lead Sponsor
- Capital Medical University Affiliated Beijing Traditional Chinese Medicine Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- Not specified
(1) Meet the diagnostic criteria for sepsis PICS: presence of infection, SOFA score = 2, and hospitalization for more than 14 days, and fulfillment of at least two of the following three indicators: C-reactive protein (CRP) > 2.0 mg/dL, albumin (Albumin, Alb) < 3.0 g/dL, lymphocytes < 800/µL.
(2) Age = 18 years;
(3) Voluntarily participate in this study and sign the informed consent form.
(1) Pregnant or planning to become pregnant;
(2) Severe mental illness;
(3) Expected survival time of less than 28 days due to underlying diseases, such as uncontrolled malignant tumors or a heart attack within the past 30 days;
(4) Vegetative state;
(5) Diagnosed or highly suspected of having an acute infectious disease, such as active viral hepatitis or active tuberculosis;
(6) Allergy to the active ingredient or excipients of the trial drug;
(7) Participated in a clinical intervention trial within the past 3 months.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method